FRAZIER LIFE SCIENCES MANAGEMENT, L.P.
Latest 13F filing data - Q4 2025
Holdings (Top positions)
| Stock | Ticker | ||
|---|---|---|---|
 | ERAS | 22.73M | $84.55M |
 | NAMS | 16.94M | $594.39M |
 | PHAT | 12.47M | $206.82M |
 | TRVI | 10.26M | $128.45M |
 | ARQT | 9.87M | $286.76M |
 | SVRA | 9.86M | $59.47M |
 | MIRM | 6.80M | $536.75M |
 | MBX | 6.65M | $209.80M |
 | XLO | 5.92M | $3.79M |
 | AURA | 5.10M | $27.80M |
 | KALV | 5.04M | $81.39M |
 | AUTL | 4.62M | $9.20M |
 | MAZE | 4.57M | $189.22M |
 | LXEO | 4.42M | $43.94M |
 | MNKD | 4.22M | $23.96M |
 | ALLO | 3.87M | $5.30M |
 | BBIO | 3.55M | $271.20M |
 | DYN | 3.15M | $61.67M |
 | EOLS | 2.63M | $17.49M |
 | VOR | 2.54M | $33.27M |
Erasca, Inc.
ERAS
Shares Held
22.73M
Value
$84.55M
NewAmsterdam Pharma Company N.V.
NAMS
Shares Held
16.94M
Value
$594.39M
Phathom Pharmaceuticals, Inc.
PHAT
Shares Held
12.47M
Value
$206.82M
Trevi Therapeutics, Inc.
TRVI
Shares Held
10.26M
Value
$128.45M
Arcutis Biotherapeutics, Inc.
ARQT
Shares Held
9.87M
Value
$286.76M
Savara Inc.
SVRA
Shares Held
9.86M
Value
$59.47M
Mirum Pharmaceuticals, Inc.
MIRM
Shares Held
6.80M
Value
$536.75M
MBX Biosciences, Inc. Common Stock
MBX
Shares Held
6.65M
Value
$209.80M
Xilio Therapeutics, Inc.
XLO
Shares Held
5.92M
Value
$3.79M
Aura Biosciences, Inc.
AURA
Shares Held
5.10M
Value
$27.80M
KalVista Pharmaceuticals, Inc.
KALV
Shares Held
5.04M
Value
$81.39M
Autolus Therapeutics plc
AUTL
Shares Held
4.62M
Value
$9.20M
Maze Therapeutics, Inc.
MAZE
Shares Held
4.57M
Value
$189.22M
Lexeo Therapeutics, Inc. Common Stock
LXEO
Shares Held
4.42M
Value
$43.94M
MannKind Corporation
MNKD
Shares Held
4.22M
Value
$23.96M
Allogene Therapeutics, Inc.
ALLO
Shares Held
3.87M
Value
$5.30M
BridgeBio Pharma, Inc.
BBIO
Shares Held
3.55M
Value
$271.20M
Dyne Therapeutics, Inc.
DYN
Shares Held
3.15M
Value
$61.67M
Evolus, Inc.
EOLS
Shares Held
2.63M
Value
$17.49M
Vor Biopharma Inc.
VOR
Shares Held
2.54M
Value
$33.27M